Technology

Select Opportunities Fund II has raised $1.25bn to invest in 'recapitalisations of high-performing TA portfolio companies', the growth investor says.

East Coast technology and healthcare investor Riverside Partners increased its GP commitment by $4.25m to strengthen alignment.

Secondaries investors bought a portfolio of European tech assets off Eurazeo's balance sheet, the latest in a series of strip sales by the manager.

Lexington Partners’ tie-up with Moonfare could be the model that will allow secondaries firms to tap a lucrative new market.

The Nordics-focused manager started the Edda series of funds in 2018 to complement its longstanding direct secondaries offering.

Medical devices business Confluent accounted for a majority of NAV in a transaction involving Ampersand Capital Partners.

The process, which was also backed by two co-investors, centres on a 2010-vintage fund with 10 assets across software, technology and healthcare sectors.

The process centred around star fintech asset Trustly and included backing from Investment Corporation of Dubai and Retirement System Investment Commission of South Carolina.

The venture capital specialist has closed a $125m fund targeting primary-, early secondary- and direct investments in technology-focused buyout funds.

The second installment in our series on disruption looks at Collective Equity Ownership, which offers an alternative to the direct secondaries market.